Morningstar - Citrix Systems Inc. (CTXS) Citrix Systems: A Leaner Company With a Full Plate; Shares Fairly Valued

Report

Morningstar

Dan Romanoff

EUR 100.00 For Business Accounts Only

Citrix Systems: A Leaner Company With a Full Plate; Shares Fairly Valued

After revisiting our thesis on Citrix Systems, we are maintaining our narrow moat rating, upgrading our moat trend to stable from negative, and raising our fair value estimate to $100 per share from $88. Citrix improves software and hardware performance and enables a mobile workforce through its core infrastructure software solutions for virtualization, application delivery, monitoring, control, and remote access. After a difficult period involving an activist investor, Citrix has rationalized i...

03/07/2019 14 EN

Underlying

Citrix Systems Inc.

Citrix Systems is an enterprise software company. The company markets and licenses its solutions through multiple channels worldwide, including selling through resellers, direct and over the Web. The company's partner community comprises thousands of value-added resellers known as Citrix Solution Advisors, value-added distributors, systems integrators, independent software vendors, original equipment manufacturers and Citrix Service Providers. The company provides solutions and services that it categorizes into three inter-related and complementary areas: Workspace, Networking and Professional Services.

See profile

US1773761002 NASDAQ Stock Market United States

Provider

Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

See profile

Analysts

Dan Romanoff

Other Reports on these Companies

Moody's Investors Service

Moody's withdraws Citrix's ratings following merger with TIBCO

Moody's Investors Service ("Moody's") has withdrawn Citrix Systems, Inc.'s ("Citrix") senior unsecured notes and outlook. RATINGS RATIONALE The vast majority of Citrix's debt has been repaid following the company's merger with TIBCO Software Inc. ("TIBCO"). Citrix was acquired by private equity ...

EUR 153.95

December 19, 2022 December 19, 2022 1 EN

BusinessWire

New Study Shows Chief Information Officers Now Have Ultimate Control of Organizational Budgets and Strategies

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- CIOs now control the majority of organizational budgets and are second only to the CEO in terms of shaping and delivering business strategy, research from Citrix®, a business unit of Cloud Software Group, has found. The study was based on interviews with 3,300 business leaders working in large- and mid-market businesses across the globe. Shaping Strategy As companies strive for success against a difficult economic backdrop, they are looking to tech leaders to act as strategic business partners. According to the data: 67% of business leaders say the ...

November 17, 2022 November 17, 2022 1 EN

BusinessWire

Wrike Expands Leadership Team With Strategic Hires Focused On Customer Growth, New Markets

SAN DIEGO--(BUSINESS WIRE)-- , the most powerful work management platform, today announced the addition of two new members to its executive team, better positioning the company to handle substantial growth over the coming years. The work management category is growing rapidly, as organizations face increasing work complexities while trying to ramp up efficiency and productivity. To broaden market reach and handle the demand, Wrike brings on Thomas Scott as Chief Financial Officer. Scott will be responsible for driving Wrike’s next stage of growth as more businesses turn to the platform to tran...

September 22, 2022 September 22, 2022 1 EN

Business as Usual for No-Moat Lonza; Specialty Ingredients Carve-Out on Track for 2020

Contract manufacturer Lonza reported solid half-year results, with over CHF 2.9 billion in total sales year to date, up about 6.4% from last year and boosted by foreign exchange tailwinds. Core EBITDA margin expanded 30 basis points from last year to about 27.8%, helped slightly by new accounting standards. Management indicated that it continues to expect mid- to high-single-digit sales growth in 2019. We are maintaining our fair value estimate of CHF 210 per share and our no-moat rating. The ph...

EUR 100.00

July 25, 2019 July 25, 2019 13 EN

Joe Gemino

Joe Gemino

Sasol Provides Full-Year Production Update

No-moat Sasol provided an update on its full-year fiscal 2019 production metrics that included relatively stable liquids production. For the full year ended June 30, Sasol produced 1,470 thousand barrels of crude oil and condensate a day compared with 1,469 mboe/d in the year-ago period. However, declines continued with the companyâ€™s natural gas production, down 4% to 130.3 billion cubic feet compared with the period ended June 30, 2018. Sasol also reported flat refined products of 31.4 mmboe/d ...

EUR 100.00

July 25, 2019 July 25, 2019 12 EN

Damien Conover

Damien Conover

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

We don't expect any major changes to our AstraZeneca fair value estimate following second-quarter results that largely fell in line with our expectations and slightly ahead of consensus expectations. Overall, the company is posting leading Big Pharma sales growth with total sales up 18% operationally year over year, led by impressive cancer drug sales growth of 57%. Astra's ability to continue to bring next generation drugs to the market that address unmet medical need (especially in oncology) s...

EUR 100.00

July 25, 2019 July 25, 2019 14 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Citrix Systems: A Leaner Company With a Full Plate; Shares Fairly Valued

Moody's withdraws Citrix's ratings following merger with TIBCO

New Study Shows Chief Information Officers Now Have Ultimate Control of Organizational Budgets and Strategies

Wrike Expands Leadership Team With Strategic Hires Focused On Customer Growth, New Markets

Business as Usual for No-Moat Lonza; Specialty Ingredients Carve-Out on Track for 2020

Sasol Provides Full-Year Production Update

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe